Systemic Anti-Cancer Therapy Data Set
Information Standard Notice
Acting under delegated authority from the Secretary of State for Health, the Data Coordination Board has approved a change to an existing information standard for publication under section 250 of the Health and Social Care Act 2012.
Important: Full conformance date
You must comply with this change by the full conformance date: 1 December 2019
Standard definition
- Unique identifier
DCB1533 Amd 80/2018
- Name
- Systemic Anti-Cancer Therapy Data Set
- Approval date
- 22 November 2018
- Publication date
- 6 December 2018
- Documentation
- opens in a new tab
(opens in new tab)
Standard definition
- Description
- Captures activity data relating to the treatment of cancer with medicines.
About this change
- Scope
- NHS Services
- Applies to
- Cancer centres
- All providers of NHS commissioned systemic anti-cancer therapy services.
- Impacts upon
- Implementation of this information standard impacts all health IT systems suppliers providing systems to the above providers; suppliers should work with their customers to determine necessary changes. All commissioners of NHS funded systemic anti-cancer therapy services should review impact on business processes and enable consequential changes.
- Link to further information
- Further information
Contacts
- Sponsor
Dr Jem Rashbass, Director for National Disease Registration, Public Health England.
- SRO
- Professor John Newton, Chief Knowledge Officer, Public Health England.
- Business Lead
- Andrew Murphy, Head of Cancer Datasets, National Cancer Registration and Analysis Service, Public Health England.
- Help Desk
Dates
- Implementation Date
- 6 December 2018
- Full Conformance Date
- 1 December 2019
- Post Implementation Review date
- 31 August 2020